Evaluation of Endovenous Sclerotherapy for Treatment of Varicose Veins
Completed
- Conditions
- Varicose Veins
- Registration Number
- NCT00954980
- Lead Sponsor
- University of Oklahoma
- Brief Summary
The overall objective will be to evaluate clinical predictors of outcomes in patients who undergo endovenous sclerotherapy for the treatment of varicose veins.
- Detailed Description
A prospective cohort study of patients who undergo endovenous sclerotherapy over 2 years. There are no deviations in usual clinical assessment and care of patients seeking varicose vein treatment. The purpose of this protocol is only to collect clinical and biomarker information related to this standard treatment.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- Clinical diagnosis of varicose veins
Exclusion Criteria
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Frequency of obliteratin (total or partial) of injected varicosity. assessment will be at 1, 12, and 26 weeks. Improvement in venous stasis symptoms. assessment will be at 1, 12, and 26 weeks Change in quality of life. assessment will be at 1, 12, and 26 weeks Associations between clinical outcomes and biomarkers. assessment will be at 1, 12, and 26 weeks
- Secondary Outcome Measures
Name Time Method Recurrence of varicosities. assessment will be at 1, 12, and 26 weeks Adverse events reported following procedure. assessment will be at 1, 12, and 26 weeks
Trial Locations
- Locations (1)
University of Oklahoma Health Sciences Center campus at the OU Vascular Center
🇺🇸Oklahoma City, Oklahoma, United States